CONMED Corporation

    Jurisdiction
    United States
    LEI
    Z6C0YCECH9DCU5ZIQW84
    ISIN
    US2074101013 (CNMD)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    InsiderPie Expert Score
    50 / 100
    Even with peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    €70.10 76.1% undervalued
    Financial strength (Piotroski F-Value)
    8 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. Read full profile

    Fundamentals

    Net revenue
    €1.13B
    Gross margin
    56.1%
    EBIT
    €146.98M
    EBIT margin
    13.0%
    Net income
    €93.99M
    Net margin
    8.3%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €1.23B +8.4% €125.18M +33.2%
    €1.28B +4.4% €140.74M +12.4%
    N/A N/A

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $0.20
    Ex date
    Payment date
    Dividend payout ratio
    22.4%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Garner Todd W Executive Vice President & CFO -598 $52.45 -$31.37K

    Earnings Calls

    Earnings Calls

    Latest earnings call: April 24, 2024 (Q1 2024)

    Add to watchlist

    Notifications